-
公开(公告)号:US12178655B2
公开(公告)日:2024-12-31
申请号:US18132086
申请日:2023-04-07
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY ACADEMY CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Yukun Luo , Xiang Fei , Xirui Zhang , Maodong Sang , Lei Zhu , Yuxin Chen , Yan Zhang , Fang Xie , Yiru Wang , Duo Dong
Abstract: Embodiments of the present disclosure provide a contrast enhanced ultrasound imaging method and an ultrasound imaging device. The method may include: determining a target imaging mode from preset imaging modes in response to the first instruction, where the preset imaging modes comprise a first contrast enhanced imaging mode and a second contrast enhanced imaging mode which have different frame rate; transmitting ultrasound waves to a target object and receiving ultrasound echoes returned from the target object according to the determined target imaging mode to obtain ultrasound echo signals; and generating a contrast enhanced image according to the ultrasound echo signals. An ultrasound imaging device is also be provided.
-
公开(公告)号:US11020450B2
公开(公告)日:2021-06-01
申请号:US15748621
申请日:2016-04-19
Inventor: Yaling Han , Chenghui Yan , Dan Liu , Xiaoxiang Tian , Yang Li , Xiaolin Zhang , Haixu Song , Meili Liu
IPC: A61K38/00 , C07K14/00 , A61K38/17 , G01N33/68 , C07K14/47 , A01K67/027 , A61P9/10 , C12N15/52 , A61K48/00
Abstract: The present invention relates to a medical use of Cellular Repressor of E1A-stimulated Genes (CREG), in particular to a use of CREG protein or active fragment thereof in manufacture of a medicament for preventing and/or treating myocardial infarction, a use in manufacture of a medicament for preventing and/or treating ventricular remodeling after myocardial infarction and heart failure after myocardial infarction, a use in manufacture of a medicament for prevention and/or treatment of myocardial ischemia-reperfusion injury, a use in manufacture of a medicament for prevention and/or treatment of salt-sensitive hypertensive myocardial fibrosis.
-
公开(公告)号:US20200281571A1
公开(公告)日:2020-09-10
申请号:US16883884
申请日:2020-05-26
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY ACADEMY CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Yukun LUO , Xiang FEI , Xirui ZHANG , Maodong SANG , Lei ZHU , Yuxin CHEN , Yan ZHANG , Fang XIE , Yiru WANG , Duo DONG
Abstract: Embodiments of the present disclosure provide a contrast enhanced ultrasound imaging method and an ultrasound imaging device. The method may include: determining a target imaging mode from preset imaging modes in response to the first instruction, where the preset imaging modes comprise a first contrast enhanced imaging mode and a second contrast enhanced imaging mode which have different frame rate; transmitting ultrasound waves to a target object and receiving ultrasound echoes returned from the target object according to the determined target imaging mode to obtain ultrasound echo signals; and generating a contrast enhanced image according to the ultrasound echo signals. An ultrasound imaging device is also be provided.
-
公开(公告)号:US20230240660A1
公开(公告)日:2023-08-03
申请号:US18132086
申请日:2023-04-07
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY ACADEMY CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Yukun LUO , Xiang FEI , Xirui ZHANG , Maodong SANG , Lei ZHU , Yuxin CHEN , Yan ZHANG , Fang XIE , Yiru WANG , Duo DONG
CPC classification number: A61B8/5207 , A61B8/06 , A61B8/461 , A61B8/481
Abstract: Embodiments of the present disclosure provide a contrast enhanced ultrasound imaging method and an ultrasound imaging device. The method may include: determining a target imaging mode from preset imaging modes in response to the first instruction, where the preset imaging modes comprise a first contrast enhanced imaging mode and a second contrast enhanced imaging mode which have different frame rate; transmitting ultrasound waves to a target object and receiving ultrasound echoes returned from the target object according to the determined target imaging mode to obtain ultrasound echo signals; and generating a contrast enhanced image according to the ultrasound echo signals. An ultrasound imaging device is also be provided.
-
公开(公告)号:US11672512B2
公开(公告)日:2023-06-13
申请号:US16883884
申请日:2020-05-26
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY ACADEMY CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Yukun Luo , Xiang Fei , Xirui Zhang , Maodong Sang , Lei Zhu , Yuxin Chen , Yan Zhang , Fang Xie , Yiru Wang , Duo Dong
CPC classification number: A61B8/5207 , A61B8/06 , A61B8/461 , A61B8/481
Abstract: Embodiments of the present disclosure provide a contrast enhanced ultrasound imaging method and an ultrasound imaging device. The method may include: determining a target imaging mode from preset imaging modes in response to the first instruction, where the preset imaging modes comprise a first contrast enhanced imaging mode and a second contrast enhanced imaging mode which have different frame rate; transmitting ultrasound waves to a target object and receiving ultrasound echoes returned from the target object according to the determined target imaging mode to obtain ultrasound echo signals; and generating a contrast enhanced image according to the ultrasound echo signals. An ultrasound imaging device is also provided.
-
6.
公开(公告)号:US20190216894A1
公开(公告)日:2019-07-18
申请号:US16323950
申请日:2017-07-26
Inventor: Yaling HAN , Xiaoxiang TIAN , Chenghui YAN , Quanyu ZHANG , Xiaolin ZHANG , Dan LIU
CPC classification number: A61K38/1709 , A61K38/17 , A61P1/16 , A61P3/04 , A61P3/06 , A61P3/08 , A61P5/50
Abstract: Described is the use of an E1A activating gene repressor (CREG) protein, in particular to a use of a CREG protein or an active fragment thereof in manufacture of a medicament for prevention and/or treatment of overweight, obesity, insulin resistance, hyperlipidemia and related diseases. Also described is the use of a recombinant vector or recombinant cell expressing a CREG protein or an active fragment thereof in manufacture of a medicament for prevention and/or treatment of overweight, obesity, insulin resistance, hyperlipidemia and related diseases.
-
公开(公告)号:US11737734B2
公开(公告)日:2023-08-29
申请号:US16849958
申请日:2020-04-15
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY RESEARCH INSTITUTE CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Xirui Zhang , Jie Tang , Yukun Luo , Mingbo Zhang , Maodong Sang , Lanxi Xiang , Donghai Qin , Wei Fan
CPC classification number: A61B8/481 , G06T5/007 , G06T5/50 , G06T7/0012 , A61B8/5207 , G06T2207/10132 , G06T2207/20056
Abstract: An ultrasound imaging device and system, and an image enhancement method for ultrasound radiography and imaging. Image enhancement coefficients of location points in a examined biological tissue are computed first according to radiography channel data, and then, weighted processing is performed on the image enhancement coefficients and beam forming data.
-
8.
公开(公告)号:US20200253586A1
公开(公告)日:2020-08-13
申请号:US16849958
申请日:2020-04-15
Applicant: BEIJING SHEN MINDRAY MEDICAL ELECTRONICS TECHNOLOGY RESEARCH INSTITUTE CO., LTD. , GENERAL HOSPITAL OF CHINESE PLA , SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Inventor: Xirui ZHANG , Jie TANG , Yukun LUO , Mingbo ZHANG , Maodong SANG , Lanxi XIANG , Donghai QIN , Wei FAN
Abstract: An ultrasound imaging device and system, and an image enhancement method for ultrasound radiography and imaging. Image enhancement coefficients of location points in a examined biological tissue are computed first according to radiography channel data, and then, weighted processing is performed on the image enhancement coefficients and beam forming data.
-
公开(公告)号:US20200147172A1
公开(公告)日:2020-05-14
申请号:US16474903
申请日:2017-12-21
Inventor: Yaling HAN , Quanyu ZHANG , Chenghui YAN , Xiaoxiang TIAN
IPC: A61K38/17 , C12N15/85 , A61P3/10 , A01K67/027
Abstract: The present invention relates to a use of cellular repressor of E1A-stimulated genes (CREG) protein, and in particular to a use of a CREG protein or an active fragment thereof in manufacture of a medicament for the prevention and/or treatment of a fatty liver disease and type 2 diabetes. The present invention also relates to a use of a recombinant vector or recombinant cell expressing a CREG protein or an active fragment thereof in manufacture of a medicament for the prevention and/or treatment of a fatty liver disease and type 2 diabetes. The invention also relates to a corresponding kit, such as a kit used for the predication and/or evaluation of therapeutic effect and prognosis of a fatty liver disease and type 2 diabetes.
-
-
-
-
-
-
-
-